Public–private partnerships to revitalize psychiatric drug discovery

By Brady Linda S   Potter William Z  

Expert Opinion on Drug Discovery, Vol. 9, Iss. 1, 2014-01 ,pp. : 1-8

Informa Healthcare

Access to resources Recommend Favorite

Quantitative Benefit-Risk Analysis for Evaluating Drug Therapies

By Kodell Ralph L.   Chen James J.  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 1, 2013-01 ,pp. : 231-238

Taylor & Francis Ltd

Access to resources Recommend Favorite

National Cooperative Drug Discovery Groups (NCDDGs): A Successful Model for Public Private Partnerships in Cancer Drug Discovery

By Hallock Yali   Cragg Gordon  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 41, Iss. 1, 2003-12 ,pp. : 78-91

Informa Healthcare

Access to resources Recommend Favorite

A Cell Fractionation Approach for the Quantitative Analysis of Subcellular Drug Disposition

By Duvvuri Muralikrishna   Feng Wenhong   Mathis Amanda   Krise Jeffrey P.  

Pharmaceutical Research, Vol. 21, Iss. 1, 2004-01 ,pp. : 26-32

Springer Publishing Company

Access to resources Recommend Favorite

Quantitative Structure-Activity Relationship (QSAR) Analysis to Predict Drug-Drug Interactions of ABC Transporter ABCG2

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 6, 2012-06 ,pp. : 505-514

Bentham Science Publishers

Access to resources Recommend Favorite